Felypressin

As an artificially synthesized peptide vascular active mediator, phenylpropanoid breaks the pharmacological limitations of natural felypressin derivatives by precise site modification and peptide chain reconstruction of the molecular structure of natural peptide, forming unique and distinctive pharmacological properties. The specificity of its target and the accuracy of physiological regulation are significantly improved. In the entire process of surgical practice and clinical anesthesia intervention, the body often faces multiple disturbances such as stress reactions caused by traumatic stimuli, circulation fluctuations caused by intraoperative fluid loss, and neural regulation disorders under the influence of anesthetic drugs, which can easily induce a series of perioperative complications such as circulatory imbalance, acute circulatory failure, and abnormal bleeding in the surgical area, seriously affecting the surgical process and patient prognosis.

 

Our Products

 

​

Felypressin COA

Certificate of Analysis
Compound name	Felypressin
Grade	Pharmaceutical grade
CAS No.	56-59-7
Quantity	36g
Packaging standard	PE bag+Al foil bag
Manufacturer	Shaanxi BLOOM TECH Co., Ltd
Lot No.	202601090088
MFG	Jan 9th 2026
EXP	Jan 8th 2029
Structure
Item	Enterprise standard	Analysis result
Appearance	White or almost white powder	Conformed
Water content	≤5.0%	0.54%
Loss on drying	≤1.0%	0.42%
Heavy Metals	Pb≤0.5ppm	N.D.
	As≤0.5ppm	N.D.
	Hg≤0.5ppm	N.D.
	Cd≤0.5ppm	N.D.
Purity (HPLC)	≥99.0%	99.98%
Single impurity	<0.8%	0.52%
Total microbial count	≤750cfu/g	95
E. Coli	≤2MPN/g	N.D.
Salmonella	N.D.	N.D.
Ethanol (by GC)	≤5000ppm	500ppm
Storage	Store in a sealed, dark, and dry place below -20°C

By virtue of its highly directional vascular regulatory ability, phenylpropanoid exerts precise effects on peripheral vascular related receptors, gradually demonstrating three core advantages of circulatory homeostasis regulation, long-term smoothing effect, and efficient contraction efficacy, effectively avoiding many disadvantages of traditional vasoactive substances and becoming an important auxiliary substance for perioperative pathological state correction and complication prevention and control. Based on this, this article will focus on the three core functions and characteristics of this substance, and conduct in-depth analysis from multiple dimensions such as mechanism of action, efficacy performance, and clinical adaptability, further clarifying its application value and clinical adaptation logic in surgical anesthesia scenarios.

Triple perioperative intervention efficacy in surgical and anesthesia settings

The traumatic stimulation of surgical operations, the inhibitory effect of anesthetic drugs on the body's nervous fluid regulatory system, and the inevitable loss of body fluids during surgery collectively constitute multiple disturbance factors in the perioperative period of the body. These factors overlap and easily disrupt the original physiological balance of the body, causing a series of difficult problems such as abnormal peripheral circulation tension, acute circulatory failure, and excessive bleeding from the surgical site wound.

They not only interfere with the smooth progress of surgical operations, but may also increase the incidence of perioperative complications in patients and affect prognosis recovery.

Phenylpropanoid, with its unique molecular structure advantage, can specifically bind to relevant receptors on the surface of peripheral vascular smooth muscle, and achieve targeted correction of pathological abnormalities in the body by accurately regulating vascular contraction and relaxation states.

It plays a triple core intervention role in maintaining circulatory homeostasis, antagonizing acute circulatory failure, and controlling intraoperative bleeding during the perioperative period, providing strong support for the safe development of surgical and anesthesia interventions.

01

Cycle steady-state maintenance efficiency:

During the surgical process, surgical trauma can directly damage the peripheral vascular wall structure, leading to a decrease in vascular smooth muscle tension, which in turn can cause a decrease in peripheral circulation resistance and arterial perfusion pressure deviation. If not intervened in a timely manner, problems such as insufficient tissue and organ perfusion and accelerated heart rate compensation may occur. Felypressin can gradually activate peripheral vascular receptors, slowly regulate the contraction amplitude of vascular smooth muscle, gradually increase peripheral vascular tension, gently correct transient circulatory depression during surgery, and maintain core hemodynamic indicators such as arterial blood pressure and heart rate in a stable range. This not only avoids the adverse effects caused by sudden increases and decreases in blood pressure, but also adapts to the circulation control needs of various complex surgical procedures (such as long-term open surgery and surgery for critically ill patients), creating a stable physiological environment for surgical operations.

02

Antagonistic efficacy against acute circulatory failure:

In extreme situations such as severe trauma and massive blood loss, the body is prone to acute circulatory failure such as shock. At this time, peripheral blood vessels are excessively dilated and microcirculation perfusion is severely insufficient. If it continues to develop, it can cause tissue hypoxia, metabolic disorders, and even endanger life. Phenylpropanoid can activate peripheral vascular smooth muscle receptors through targeted activation, rapidly reconstruct the systemic vascular resistance network, constrict blood vessels in peripheral non vital organs, prioritize limited blood supply to core organs such as the heart and brain, effectively block tissue damage chain reactions caused by low perfusion, delay the progression of shock pathology, and assist in improving microcirculation blood flow velocity and perfusion efficiency, buying valuable time for subsequent fluid resuscitation and etiological treatment.

03

Control effectiveness of vascular leakage in the surgical area:

The rupture of small blood vessels in surgical wounds can lead to persistent bleeding, which not only causes loss of blood volume in the body, but also blurs the surgical field of view, increases the difficulty of surgical operation and the risk of intraoperative injury, and even prolongs the surgical duration. It can directly tighten the smooth muscle tissue of microvessels throughout the body, reduce the permeability coefficient of microvascular walls, decrease the extravasation of fluid and blood components in the blood vessels, and inhibit the involuntary abnormal contraction of superficial blood vessels in the surgical field, thereby reducing the total amount of extravasation from the source. This control effect can effectively streamline the operation process of manual hemostasis (such as electrocoagulation and compression hemostasis) during surgery, significantly improve the clarity of the surgical field, reduce the frequency of application of combined hemostatic agents, and lower the potential risk of adverse reactions caused by hemostatic drugs.

The sources of information cited above are:

Research progress on pharmacological characteristics and clinical application of perioperative vasoactive peptide drugs, Clinical Pharmacology Bulletin
Vascular reactivity of synthetic peptide analogs in systemic circulation regulation,Journal of Cardiovascular Pharmacology
Comparative analysis of the efficacy of artificially synthesized nine peptide vasoconstrictors, Chinese Journal of Pathophysiology

Compared to lysine vasopressin, it has the advantage of vascular constriction efficacy

Felypressin and lysine vasopressin belong to the vasopressin family of active peptide substances, but after artificial structural modification, they have achieved significant improvement in the core biological activity of vascular constriction. There is a clear quantitative difference in pharmacological strength between the two, and the former exhibits better clinical compatibility.

01.Basic contraction activity has multiple advantages:
Through in vivo model experiments and in vitro tissue testing data, it has been confirmed that the substance has a contraction activation ability for peripheral resistance vessels that is five times that of lysine vasopressin. With the same intervention goals achieved, the dosage can be significantly reduced, and the potential risk of excessive accumulation of exogenous substances can be reduced.

02.Synergistic improvement of targeting and contraction strength:
While enhancing vascular constriction, its target is highly focused on key peripheral circulation vessels, with weak intervention on deep organ associated blood vessels, achieving a dual balance of effective regulation and physiological safety, and reducing adverse stress reactions in non targeted tissues.
03.High intensity and efficient adaptation to complex pathological scenarios:
In the face of difficult situations such as severe circulatory resistance and extensive wound bleeding during surgery, high fold contraction activity can quickly achieve physiological state correction. Compared with the less effective lysine vasopressin, its clinical applicability is broader and its adaptability to pathological intervention is stronger.

The sources of information cited above are:

Metabolic characteristics of synthetic pressor agents during prolonged surgical procedures,Anesthesia Science Reviews
A review of research on optimizing the structure-activity relationship of peptide vasoactive substances and pharmaceutical progress

References

Duration and stability of pressor effects induced by modified vasopressin peptides,Critical Care Research
Exploration of the mechanism of action of peripheral vascular regulatory drugs in shock state, Chinese Journal of Emergency Medicine
Comparative vasoconstrictor potency of lysine vasopressin and novel peptide analogs,Peptides
Exploration of Clinical Applicability of Long acting Hemodynamic Regulating Drugs, Surgical Theory and Practice

FAQ

• What is the use of it?

Felypressin (FEL), a synthetic analogue of vasopressin (AVP), has been widely used as a substitute for epinephrine (EPI) in anesthetic solutions to promote local vasoconstriction during medical and dental practices.

• Why is this peptide contraindicated in pregnancy?

This was contraindicated due to its oxytocic properties and high risk of inducing uterine contractions. Conclusions: Among vasoconstrictors, epinephrine remains the only agent with an acceptable safety profile in pregnancy when used correctly.

• What LA has this?

Citanest DENTAL contains the active ingredients prilocaine hydrochloride and this. It is used to prevent or relieve pain during dental procedures.

• Does prilocaine contain it?

It contains prilocaine hydrochloride and Octapressin (which contains felypressin). Prilocaine hydrochloride is a type of medicine called a local anaesthetic. These are medicines which numb an area of the body.

Hot Tags: felypressin, China felypressin manufacturers, suppliers